|
1
|
Vanhoecke B, Bateman E, Mayo B, Vanlancker
E, Stringer A, Thorpe D and Keefe D: Dark Agouti rat model of
chemotherapy-induced mucositis: Establishment and current state of
the art. Exp Biol Med (Maywood). 240:725–741. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Murray RK, Granner DK, Mayes PA and
Rodwell VW: Harper's Biochemistry. 25th Edition, McGraw-Hill,
Health Profession Division, New York, 225, 2000.
|
|
3
|
Ikuno N, Soda H, Watanabe M and Oka M:
Irinotecan (CPT-11) and characteristic mucosal changes in the mouse
ileum and cecum. J Natl Cancer Inst. 87:1876–1883. 1995.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Takasuna K, Hagiwara T, Hirohashi M, Kato
M, Nomura M, Nagai E, Yokoi T and Kamataki T: Involvement of
beta-glucuronidase in intestinal microflora in the intestinal
toxicity of the antitumor camptothecin derivative irinotecan
hydrochloride (CPT-11) in rats. Cancer Res. 56:3752–3757.
1996.PubMed/NCBI
|
|
5
|
Potten CS, Wilson JW and Booth C:
Regulation and significance of apoptosis in the stem cells of the
gastrointestinal epithelium. Stem Cells. 15:82–93. 1997.PubMed/NCBI View Article : Google Scholar
|
|
6
|
McLaughlin MM, Dacquisto MP, Jacobus DP
and Horowitz RE: Effects of the germ-free state on responses of
mice to whole-body irradiation. Radiat Res. 23:333–349.
1964.PubMed/NCBI
|
|
7
|
Pedroso SHSP, Vieira AT, Bastos RW,
Oliveira JS, Cartelle CT, Arantes RME, Soares PMG, Generoso SV,
Cardoso VN, Teixeira MM, et al: Evaluation of mucositis induced by
irinotecan after microbial colonization in germ-free mice.
Microbiology (Reading). 161:1950–1960. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Brandi G, Dabard J, Raibaud P, Di Battista
M, Bridonneau C, Pisi AM, Morselli Labate AM, Pantaleo MA, De Vivo
A and Biasco GI: Intestinal microflora and digestive toxicity of
irinotecan in mice. Clin Cancer Res. 12:1299–1307. 2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lin XB, Dieleman LA, Ketabi A, Bibova I,
Sawyer MB, Xue H, Field CJ, Baracos VE and Gänzle MG: Irinotecan
(CPT-11) chemotherapy alters intestinal microbiota in tumour
bearing rats. PLoS One. 7(e39764)2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Montassier E, Gastinne T, Vangay P,
Al-Ghalith GA, Bruley des Varannes S, Massart S, Moreau P, Potel G,
de La Cochetière MF, Batard E and Knights D: Chemotherapy-driven
dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther.
42:515–528. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zwielehner J, Lassl C, Hippe B, Pointner
A, Switzeny OJ, Remely M, Kitzweger E, Ruckser R and Haslberger AG:
Changes in human fecal microbiota due to chemotherapy analyzed by
TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PLoS One.
6(e28654)2011.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Panebianco C, Adamberg K, Jaagura M,
Copetti M, Fontana A, Adamberg S, Kolk K, Vilu R, Andriulli A and
Pazienza V: Influence of gemcitabine chemotherapy on the microbiota
of pancreatic cancer xenografted mice. Cancer Chemother Pharmacol.
81:773–782. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li HL, Lu L, Wang XS, Qin LY, Wang P, Qiu
SP, Wu H, Huang F, Zhang BB, Shi HL, et al: Alteration of gut
microbiota and inflammatory cytokine/chemokine profiles in
5-fluorouracil induced intestinal mucositis. Front Cell Infect
Microbiol. 7(455)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Alexander JL, Wilson ID, Teare J, Marchesi
JR, Nicholson JK and Kinross JM: Gut microbiota modulation of
chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol.
14:356–365. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Logan R, Stringer A, Bowen J, Gibson R,
Sonis S and Keefe D: Is the pathobiology of chemotherapy-induced
alimentary tract mucositis influenced by the type of mucotoxic drug
administered? Cancer Chemother Pharmacol. 63:239–251.
2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Stringer AM, Gibson RJ, Logan RM, Bowen
JM, Yeoh AS, Hamilton J and Keefe DM: Gastrointestinal microflora
and mucins may play a critical role in the development of
5-fluorouracil-induced gastrointestinal mucositis. Exp Biol Med.
234:430–441. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Simon GL and Gorbach SL: Intestinal flora
in health and disease. Gastroenterology. 86:174–193.
1984.PubMed/NCBI
|
|
18
|
Simon GL and Gorbach SL: The human
intestinal microflora. Dig Dis Sci. 31 (Suppl 9):S147–S162.
1986.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Cario E: Bacterial interactions with cells
of the intestinal mucosa: Toll-like receptors and NOD2. Gut.
54:1182–1193. 2005.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sonis ST: The pathobiology of mucositis.
Nat Rev Cancer. 4:277–284. 2004.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cario E: Toll-like receptors in the
pathogenesis of chemotherapy-induced gastrointestinal toxicity.
Curr Opin Support Palliat Care. 10:157–164. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Cario E: Microbiota and innate immunity in
intestinal inflammation and neoplasia. Curr Opin Gastroenterol.
29:85–91. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Shatz M, Menendez D and Resnick MA: The
human TLR innate immune gene family is differentially influenced by
DNA stress and p53 status in cancer cells. Cancer Res.
72:3948–3957. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Smith CL, Geier MS, Yazbeck R, Torres DM,
Butler RN and Howarth GS: Lactobacillus fermentum BR11 and
fructo-oligosaccharide partially reduce jejunal inflammation in a
model of intestinal mucositis in rats. Nutr Cancer. 60:757–767.
2008.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Prisciandaro LD, Geier MS, Butler RN,
Cummins AG and Howarth GS: Probiotic factors partially improve
parameters of 5-fluorouracil-induced intestinal mucositis in rats.
Cancer Biol Ther. 11:671–677. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Justino PF, Melo LF, Nogueira AF, Morais
CM, Mendes WO, Franco AX, Souza EP, Ribeiro RA, Souza MH and Soares
PM: Regulatory role of Lactobacillus acidophilus on
inflammation and gastric dysmotility in intestinal mucositis
induced by 5-fluorouracil in mice. Cancer Chemother Pharmacol.
75:559–567. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Levit R, Savoy de Giori G, de Moreno de
LeBlanc A and LeBlanc JG: Protective effect of the
riboflavin-overproducing strain Lactobacillus plantarum
CRL2130 on intestinal mucositis in mice. Nutrition. 54:165–172.
2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yeung CY, Chiang Chiau JS, Cheng ML, Chan
WT, Chang SW, Chang YH, Jiang CB and Lee HC: Modulations of
probiotics on gut microbiota in a 5-fluorouracil-induced mouse
model of mucositis. J Gastroenterol Hepatol. 35:806–814.
2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Quaresma M, Damasceno S, Monteiro C, Lima
F, Mendes T, Lima M, Justino P, Barbosa A, Souza M, Souza E, et al:
Probiotic mixture containing Lactobacillus spp. and
Bifidobacterium spp. attenuates 5-fluorouracil-induced
intestinal mucositis in mice. Nutr Cancer. 72:1355–1365.
2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Chen H, Zhang F, Li R, Liu Y, Wang X,
Zhang X, Xu C, Li Y, Guo Y and Yao Q: Berberine regulates fecal
metabolites to ameliorate 5-fluorouracil induced intestinal
mucositis through modulating gut microbiota. Biomed Pharmacother.
124(109829)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ciobanu L, Tantau M, Valean S, Parau A,
Bedecean I, Mîrleneanu R, Berce C, Catoi C and Taulescu M:
Rifaximin modulates 5-fluorouracil-induced gastrointestinal
mucositis in rats. Eur Rev Med Pharmacol Sci. 20:4993–5001.
2016.PubMed/NCBI
|
|
32
|
Fu C, Chu J, Shen A, Liu L, Chen H, Lin J,
Sferra TJ, Chen Y and Peng J: Pien Tze Huang alleviates
5-fluorouracil-induced intestinal mucositis in CT-26 tumor-bearing
mice. Exp Ther Med. 14:2291–2297. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Picó-Monllor JA and Mingot-Ascencao JM:
Search and selection of probiotics that improve mucositis symptoms
in oncologic patients. A systematic review. Nutrients.
11(2322)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Gaudana SB, Dhanani AS and Bagchi T:
Probiotic attributes of Lactobacillus strains isolated from
food and of human origin. Br J Nutr. 103:1620–1628. 2010.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Liu YW, Liong MT and Tsai YC: New
perspectives of Lactobacillus plantarum as a probiotic: The
gut-heart-brain axis. J Microbiol. 56:601–613. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Howarth GS, Francis GL, Cool JC, Xu X,
Byard RW and Read LC: Milk growth factors enriched from cheese whey
ameliorate intestinal damage by methotrexate when administered
orally to rats. J Nutr. 126:2519–2530. 1996.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Le Mandat Schultz A, Bonnard A, Barreau F,
Aigrain Y, Pierre-Louis C, Berrebi D and Peuchmaur M: Expression of
TLR-2, TLR-4, NOD2 and pNF-kappaB in a neonatal rat model of
necrotizing enterocolitis. PLoS One. 2(e1102)2007.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Frolova L, Drastich P, Rossmann P,
Klimesova K and Tlaskalova-Hogenova H: Expression of Toll-like
receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients
with inflammatory bowel diseases: Upregulated expression of TLR2 in
terminal ileum of patients with ulcerative colitis. J Histochem
Cytochem. 56:267–274. 2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Sonis ST, Elting LS, Keefe D, Peterson DE,
Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly
JP, Rubenstein EB, et al: Perspectives on cancer therapy-induced
mucosal injury: Pathogenesis, measurement, epidemiology, and
consequences for patients. Cancer. 100 (Suppl 9):S1995–S2025.
2004.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Levit R, Savoy de Giori G, de Moreno de
LeBlanc A and LeBlanc JG: Effect of riboflavin-producing bacteria
against chemically induced colitis in mice. J Appl Microbiol.
124:232–240. 2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Caballero-Franco C, Keller K, De Simone C
and Chadee K: The VSL#3 probiotic formula induces mucin gene
expression and secretion in colonic epithelial cells. Am J Physiol
Gastrointest Liver Physiol. 292:G315–G322. 2007.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Tang Y, Wu Y, Huang Z, Dong W, Deng Y,
Wang F, Li M and Yuan J: Administration of probiotic mixture DM#1
ameliorated 5-fluorouracil-induced intestinal mucositis and
dysbiosis in rats. Nutrition. 33:96–104. 2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ribeiro RA, Wanderley CW, Wong DV, Mota
JM, Leite CA, Souza MH, Cunha FQ and Lima-Júnior RC: Irinotecan-
and 5-fluorouracil-induced intestinal mucositis: Insights into
pathogenesis and therapeutic perspectives. Cancer Chemother
Pharmacol. 78:881–893. 2016.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Zhang J, Yi R, Qian Y, Sun P, Zhao X and
Yang Z: Lactobacillus plantarum CQPC06 activity prevents
dextran sulfate sodium-induced colitis by regulating the IL-8
pathway. J Food Sci. 83:2653–2661. 2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Laiño J, Villena J, Kanmani P and
Kitazawa H: Immunoregulatory effects triggered by lactic acid
bacteria exopolysaccharides: New insights into molecular
interactions with host cells. Microorganisms. 4(27)2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Murofushi Y, Villena J, Morie K, Kanmani
P, Tohno M, Shimazu T, Aso H, Suda Y, Hashiguchi K, Saito T and
Kitazawa H: The Toll-like receptor family protein RP105/MD1 complex
is involved in the immunoregulatory effect of exopolysaccharides
from Lactobacillus plantarum N14. Mol Immunol. 64:63–75.
2015.PubMed/NCBI View Article : Google Scholar
|
